Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

ZX-101A inhibits tumor growth by enhancing antitumor immunity

April 20, 2021

TP-5809 shows potent inhibition of tumor growth in a model of Hodgkin's lymphoma

April 20, 2021

BO-2762: a potential candidate for colorectal cancer

April 20, 2021

Betta Pharmaceuticals identifies IDH2 mutant inhibitors

April 20, 2021

Roche discloses MGL inhibitors

April 20, 2021

BeiGene patents new PROTACs for cancer

April 20, 2021

Genentech's GNE-7883 inhibits YAP/TAZ-TEAD interaction

April 20, 2021

Zenshine PI3Kgamma inhibitor ZX-4081 functions by reprogramming the tumor microenvironment

April 20, 2021

Loxo Oncology presents next-generation RET inhibitor candidates

April 19, 2021

Shenzhen Targetrx Biotechnology synthesizes Ret inhibitors

April 19, 2021

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...